10.5281/zenodo.4730953
https://zenodo.org/records/4730953
oai:zenodo.org:4730953
Ayoubi, Riham
Riham
Ayoubi
0000-0001-6633-655X
Montreal Neurological Institute
Alshafie, Walaa
Walaa
Alshafie
0000-0001-7999-1297
Montreal Neurological Institute
Nicouleau, Michael
Michael
Nicouleau
0000-0001-9319-3355
Montreal Neurological Institute
Durcan, Thomas M.
Thomas M.
Durcan
0000-0003-3942-1956
Montreal Neurological Institute
McPherson, Peter S.
Peter S.
McPherson
0000-0001-7806-5662
Montreal Neurological Institute
Laflamme, Carl
Carl
Laflamme
0000-0001-5906-025X
Montreal Neurological Institute
Antibody Characterization Report for Peroxiredoxin-6
Zenodo
2021
Peroxiredoxin-6
PRDX6
P30041
antibody validation
antibody characterization
2021-04-30
eng
10.5281/zenodo.4730952
https://zenodo.org/communities/treatad
https://zenodo.org/communities/sgc-opennotebook
https://zenodo.org/communities/openlabnotebooks
https://zenodo.org/communities/ycharos
Creative Commons Attribution 4.0 International
Head to head comparison of available commercial antibodies against Peroxiredoxin-6 by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
National Institutes of Health
10.13039/100000002
3RF1AG057443-01S2
Infrastructure to improve reliability of AMP-AD target hypotheses